Amplitude Surgical SA
EPA:AMPLI.PA
3.16 (EUR) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 106 | 100.2 | 87.559 | 82.713 | 88.286 | 102.559 | 100.336 | 93.356 | 80.788 | 71.09 | 58.228 | 50.268 | 47.249 | 0 |
| Cost of Revenue
| 31.3 | 64.475 | 60.005 | 60.377 | 70.114 | 49.872 | 50.175 | 49.843 | 42.886 | 38.579 | 31.389 | 13.224 | 13.86 | 0 |
| Gross Profit
| 74.7 | 35.725 | 27.554 | 22.336 | 18.172 | 52.687 | 50.161 | 43.513 | 37.902 | 32.511 | 26.839 | 37.044 | 33.389 | 0 |
| Gross Profit Ratio
| 0.705 | 0.357 | 0.315 | 0.27 | 0.206 | 0.514 | 0.5 | 0.466 | 0.469 | 0.457 | 0.461 | 0.737 | 0.707 | 0 |
| Reseach & Development Expenses
| 1.5 | 1.776 | 1.837 | 2.547 | 4.1 | 3.945 | 3.454 | 7.072 | 7.327 | 6.045 | 4.592 | 4.25 | 0 | 0 |
| General & Administrative Expenses
| 0 | 2.81 | 2.506 | 2.44 | 2.614 | 3.1 | 2.923 | 2.392 | 2.558 | 2.093 | 1.818 | 1.54 | 1.525 | 3.399 |
| Selling & Marketing Expenses
| 0 | 0.422 | 0.39 | 0.173 | 0.828 | 1.071 | 1.344 | 1.375 | 0.891 | 0.704 | 0.652 | 11.961 | 9.906 | 0 |
| SG&A
| 46 | 23.732 | 18.635 | 17.752 | 19.581 | 30.836 | 29.697 | 26.258 | 20.189 | 16.023 | 12.602 | 13.501 | 11.431 | 3.399 |
| Other Expenses
| -47.2 | 3.61 | -0.352 | -1.085 | 6.785 | -3.791 | -4.369 | -2.683 | -1.701 | 0 | 0 | 14.536 | 12.106 | 0 |
| Operating Expenses
| 94.7 | 21.898 | 20.824 | 21.384 | 16.896 | 53.57 | 52.028 | 45.552 | 34.874 | 37.947 | 22.626 | 32.055 | 27.481 | 3.399 |
| Operating Income
| -20 | 13.827 | 6.73 | 0.952 | 1.276 | 2.942 | 2.378 | -0.029 | 3.463 | 5.124 | 4.446 | 4.937 | 4.937 | -3.399 |
| Operating Income Ratio
| -0.189 | 0.138 | 0.077 | 0.012 | 0.014 | 0.029 | 0.024 | -0 | 0.043 | 0.072 | 0.076 | 0.098 | 0.104 | 0 |
| Total Other Income Expenses Net
| 20 | -20.105 | -8.658 | -13.208 | -13.042 | -10.678 | -10.746 | -9.556 | -6.37 | -24.692 | -8.345 | -7.624 | -8.127 | 0 |
| Income Before Tax
| 1.073 | -6.278 | -1.928 | -12.256 | -11.766 | -7.736 | -8.368 | -9.556 | -2.907 | -19.568 | -3.899 | -2.635 | -2.219 | -3.399 |
| Income Before Tax Ratio
| 0.01 | -0.063 | -0.022 | -0.148 | -0.133 | -0.075 | -0.083 | -0.102 | -0.036 | -0.275 | -0.067 | -0.052 | -0.047 | 0 |
| Income Tax Expense
| -0.1 | 0.489 | 0.894 | 1.415 | 2.876 | 1.666 | 1.224 | 2.758 | 2.733 | 1.847 | 1.359 | -0.486 | -0.203 | -1.133 |
| Net Income
| 1.5 | 39.246 | -4.392 | -14.099 | -14.198 | -8.989 | -9.446 | -12.052 | 0.219 | -17.646 | -2.846 | -2.149 | -2.017 | -2.266 |
| Net Income Ratio
| 0.014 | 0.392 | -0.05 | -0.17 | -0.161 | -0.088 | -0.094 | -0.129 | 0.003 | -0.248 | -0.049 | -0.043 | -0.043 | 0 |
| EPS
| 0.031 | 0.82 | -0.092 | -0.29 | -0.3 | -0.19 | -0.2 | -0.26 | 0.005 | -0.38 | -0.089 | -0.067 | -0.063 | -0.071 |
| EPS Diluted
| 0.031 | 0.82 | -0.092 | -0.29 | -0.3 | -0.19 | -0.2 | -0.26 | 0.005 | -0.38 | -0.089 | -0.067 | -0.063 | -0.071 |
| EBITDA
| -22.5 | 26.801 | 19.497 | 15.585 | 20.626 | 20.268 | 18.167 | 10.854 | 12.638 | 12.236 | 10.092 | 9.488 | 9.334 | -3.399 |
| EBITDA Ratio
| -0.212 | 0.267 | 0.223 | 0.188 | 0.234 | 0.198 | 0.181 | 0.116 | 0.156 | 0.172 | 0.173 | 0.189 | 0.198 | 0 |